Genetics

CRISPR Therapeutics stock price slides after takeover-chatter spike
···

CRISPR Therapeutics stock price slides after takeover-chatter spike

CRISPR Therapeutics shares dropped 4.7% to $58.82 in early Nasdaq trading Friday, erasing part of Thursday’s 11% surge tied to revived takeover speculation flagged by Betaville and The Fly. Investors await updates on Casgevy’s launch at early March conferences. Short interest stands near 26% of the float. Casgevy generated $54 million in Q4 revenue, with $116 million reported for 2025.
February 27, 2026

Stock Market Today

  • Safety Technology Giant Gains Investor Attention Amid Market Moves
    May 30, 2026, 11:46 AM EDT. A leading safety technology company is attracting renewed market interest as investors focus on its latest advancements. The sector's innovation drive aligns with growing demand for enhanced safety solutions across industries. Market watchers note that the company's strategic developments could impact its stock performance amid evolving regulatory landscapes. Financial experts suggest keeping an eye on this firm as it navigates competitive pressures and technological progress.